Literature DB >> 2194378

Role of epidemiology in vaccine policy.

N Begg1, E Miller.   

Abstract

The application of epidemiological techniques is important at all stages in the development of a vaccination programme. Before licensing, the safety and efficacy of a new vaccine must be determined in carefully designed clinical trials. An epidemiological assessment of the disease is then needed in order to formulate an appropriate strategy for delivery of the vaccine. Once the vaccine has been introduced into routine use, continued evaluation, both of the vaccine and the programme, is required. Surveillance schemes should be established that are capable of detecting changes in vaccine safety and efficacy as well as monitoring coverage in the target population. Any important changes should be further evaluated by special studies. Postlicensing evaluation of vaccines and vaccination programmes has played an important role in shaping policy in the UK.

Mesh:

Substances:

Year:  1990        PMID: 2194378     DOI: 10.1016/0264-410x(90)90042-k

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Vaccine efficacy and control measures in pertussis.

Authors:  S R Palmer
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

3.  Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey.

Authors:  R Monina Klevens; Deanna Kruszon-Moran; Annemarie Wasley; Kathleen Gallagher; Geraldine M McQuillan; Wendi Kuhnert; Eyasu H Teshale; Jan Drobeniuc; Beth P Bell
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

4.  The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry.

Authors:  S E Robertson; M V Mayans; S Horsfall; P F Wright; J Clemens; B Ivanoff; P H Lambert
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 5.  STD vaccines--an overview.

Authors:  C T Barbosa-Cesnik; A Gerbase; D Heymann
Journal:  Genitourin Med       Date:  1997-10

6.  Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.

Authors:  Miriam Wiese-Posselt; Anette Siedler; Annette Mankertz; Andreas Sauerbrei; Hartmut Hengel; Ole Wichmann; Christina Poethko-Müller
Journal:  BMC Infect Dis       Date:  2017-05-19       Impact factor: 3.090

7.  Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.

Authors:  E Ferreras; A Blake; O Chewe; J Mwaba; G Zulu; M Poncin; A Rakesh; A L Page; M L Quilici; A S Azman; S Cohuet; I Ciglenecki; K Malama; E Chizema-Kawesha; F J Luquero
Journal:  Epidemiol Infect       Date:  2020-03-13       Impact factor: 2.451

8.  Change in Hepatitis A Seroprevalence among U.S. Children and Adolescents: Results from the National Health and Nutrition Examination Survey 2003-2006 and 2007-2010.

Authors:  Deanna Kruszon-Moran; R Monina Klevens; Geraldine M McQuillan
Journal:  Vaccines (Basel)       Date:  2013-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.